Recurrence and mortality in patients with differentiated thyroid carcinoma

Area of Science:

• Oncology
• Endocrinology
• Surgical Oncology

Background:

• Differentiated thyroid carcinoma (DTC) is the most common type of thyroid cancer.
• Identifying prognostic factors for recurrence and mortality is crucial for patient management.
• Risk stratification aids in tailoring treatment strategies for DTC patients.

Purpose of the Study:

• To investigate the distinct factors associated with recurrence and mortality in differentiated thyroid carcinoma.
• To compare risk factors between patients with initially curable and non-curable disease.
• To identify specific predictors of survival in DTC.

Main Methods:

• Retrospective analysis of 195 patients with primary differentiated thyroid carcinoma.
• Categorization of patients into 'curable' (resected primary tumor) and 'non-curable' (distant metastasis or residual tumor) groups.
• Statistical correlation analysis of patient demographics, tumor characteristics, and outcomes (recurrence, mortality).

Main Results:

• In curable patients (n=171), age, sex, and tumor size correlated with recurrence/mortality. Age was the sole significant predictor of mortality post-recurrence.
• In non-curable patients (n=24), histologic subtype significantly correlated with mortality.
• Mortality was significantly higher in non-curable patients (67%) compared to curable patients (15% recurrence, 5% mortality).

Conclusions:

• Prognostic factors for differentiated thyroid carcinoma mortality are distinct for curable and non-curable patient groups.
• Age is a critical factor influencing mortality across both patient categories.
• Histologic subtype is a significant predictor of mortality specifically in non-curable DTC patients, highlighting the need for tailored risk assessment.